KLF15 抗体 (AA 1-260)
-
- 抗原 See all KLF15 抗体
- KLF15 (Kruppel-Like Factor 15 (KLF15))
-
抗原表位
- AA 1-260
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This KLF15 antibody is un-conjugated
-
应用范围
- ELISA, Immunohistochemistry (IHC)
- 交叉反应
- 人
- 纯化方法
- Antigen Affinity Purified
- 免疫原
- Recombinant Human Krueppel-like factor 15 protein (1-260AA)
- 亚型
- IgG
- Top Product
- Discover our top product KLF15 Primary Antibody
-
-
- 应用备注
- Recommended dilution: IHC:1:20-1:200,
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- 抗原
- KLF15 (Kruppel-Like Factor 15 (KLF15))
- 别名
- KLF15 (KLF15 产品)
- 别名
- KKLF antibody, 1810013I09Rik antibody, AV048136 antibody, AW494632 antibody, CKLF antibody, Kruppel like factor 15 antibody, Kruppel-like factor 15 S homeolog antibody, Kruppel-like factor 15 antibody, KLF15 antibody, klf15.S antibody, Klf15 antibody
- 背景
-
Background: Transcriptional regulator that binds to the GA element of the CLCNKA promoter. Binds to the KCNIP2 promoter and regulates KCNIP2 circadian expression in the heart (By similarity). Is a repressor of CTGF expression, involved in the control of cardiac fibrosis. It is also involved in the control of cardiac hypertrophy acting through the inhibition of MEF2A and GATA4 (By similarity). Involved in podocyte differentiation (By similarity). Inhibits MYOCD activity. Is a negative regulator of TP53 acetylation. Inhibits NF-kappa-B activation through repression of EP300-dependent RELA acetylation.
Aliases: Kidney enriched Kruppel like factor antibody, Kidney-enriched krueppel-like factor antibody, KKLF antibody, KKLF protein antibody, KLF 15 antibody, KLF15 antibody, KLF15_HUMAN antibody, Krueppel-like factor 15 antibody, Kruppel like factor 15 antibody
- UniProt
- Q9UIH9
-